Cas:113942-30-6 Temozolomide-8-carboxylic acid manufacturer & supplier

Chemical Name:Temozolomide-8-carboxylic acid

CAS.NO:113942-30-6

Synonyms:3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid;3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid;Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3-methyl-4-oxo-;Temozolomideacid;Temozolomide-8-carboxylic acid

Molecular Formula:C₆H₅N₅O₃

Molecular Weight:195.136

HS Code:2933990090

Physical and Chemical Properties:

Melting point:177 ºC (decomp)

Boiling point:487.7±37.0 °C at 760 mmHg

Density:2.0±0.1 g/cm3

Index of Refraction:1.860

PSA:102.38000

Exact Mass:195.039246

LogP:-1.46

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Temozolomide-8-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Temozolomideacid Use and application,3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid technical grade,usp/ep/jp grade.

Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Temozolomide-8-carboxylic acid manufacturer Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. Temozolomide-8-carboxylic acid supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. Temozolomide-8-carboxylic acid vendor The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. Temozolomide-8-carboxylic acid factory The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions.